首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Drug Metabolism And Pharmacokinetics

Drug Metabolism And Pharmacokinetics杂志,由Japanese Society for the Study of Xenobiotics出版,于2002年创刊,Bimonthly,出版语言English,ISSN:1347-4367,E-ISSN:1880-0920。

投稿咨询
Drug Metabolism And Pharmacokinetics
Drug Metabolism And Pharmacokinetics
Drug Metabolism And Pharmacokinetics
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
4区
影响因子
2.2
CiteScore
5.2
期刊收录
SCI、SCIE

Drug Metabolism And Pharmacokinetics(中文译名:《药物代谢和药代动力学》),ISSN:1347-4367,EISSN:1880-0920,是Japanese Society for the Study of Xenobiotics出版的国际性学术期刊,创刊于2002年,以Bimonthly形式稳定发行,2026年总发文量约36篇。该刊采用OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.2,2025年期刊CiteScore为5.2,2025年期刊自引率约9.1%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Drug Metabolism And Pharmacokinetics长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAJapan、England、Canada、CHINA MAINLAND、South Korea、India等为核心发文国家与地区;UNIVERSITY OF WASHINGTONPFIZER、ROCHE HOLDING、MERCK & COMPANY、SHOWA PHARMACEUTICAL UNIVERSITY、ASTRAZENECA、BRISTOL-MYERS SQUIBB等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 231 / 356

35.3

学科:PHARMACOLOGY & PHARMACY SCIE Q3 183 / 356

48.74

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 209 / 352

40.8

学科:PHARMACOLOGY & PHARMACY SCIE Q3 178 / 353

49.72


中国学者近期发文

1
PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN ASTRAGALUS MEMBRANACEUS POLYSACCHARIDES AND METFORMIN IN DIABETIC MIC

Author:Zuo, Zhong; Song, Qianbo; Zou, Junju; Shaw, Pang Chui

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:

2
IN VITRO STUDY OF PAYLOAD RELEASE OF AN ANTI-TNF GLUCOCORTICOID RECEPTOR MODULATOR IMMUNOLOGY ANTIBODY-DRUG CONJUGATE (ADC-T) AND PAYLOAD METABOLIS

Author:Zhu, Mingshe; Li, Zhiqiang; Tang, Chongzhuang; Gao, Yang; Chen, Lijuan; Diao, Xingxing

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:

3
COMPHREHENSIVE METABOLITE PROFILING OF SHO0302 IN HUMAN PLASMA, URINE AND FECES USING LC-HRMS AND AN ADVANCED DATA PROCESSING WORKFLOW: COMPARISON WITH RADIOCHROMATOGRAPHIC ANALYSI

Author:Zhu, Mingshe; Yang, Yue; Tang, Chongzhuang; Diao, Xingxing

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:

4
COMPARATIVE METABOLITE PROFILING AND IDENTIFICATION OF GALNAC-CONJUGATED SIRNA, SIRNA01, IN PLASMA PREPARED WITH VARIOUS ANTICOAGULANTS, SERUM, AND IN VIVO PLASMA USING LC-UV-HRM

Author:Zhang, Hong; Chen, Tianhong; Wang, Junjie; Shi, Liqi; Qin, Gengyao; Cao, Weiqun; Tao, Yi; Shen, Liang

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:

5
EVALUATION OF DIFFERENT TISSUE PROCESSING METHODS IN BAMA PIG SKIN AS AN ANIMAL MODEL FOR TOPICAL DELIVERY SYSTEM

Author:Zhang, Chao; He, Huan; Liu, Shoutao; Hou, Lijuan; Chen, Jacob Zhi; Tao, Yi; Shen, Liang

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:

6
DOES THE FLUX COMPETITION METHOD ADD SIGNIFICANT VALUE IN SPECIES DIFFERENCE PROTEIN BINDING EVALUATION

Author:Wang, Jie; Zhao, Yuexin; Tang, Xue; Wang, Xiangling; Tao, Yi; Shen, Liang; Chen, Genfu

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:

7
DRUG METABOLISM AND PHARMACOKINETICS 61 (2025) EFFECT OF LIPOPROTEIN BINDING AND PLASMA DILUTION ON THE ACCURACY OF ULTRACENTRIFUGATION METHOD IN PLASMA PROTEIN BINDIN

Author:Wang, Jie; Lu, Chunhong; Wang, Xiangling; Tao, Yi; Shen, Liang; Chen, Genfu

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. 123-124. DOI:

8
GUT UGT ACTIVITY LOSS PRECEDES THE DEVELOPMENT OF IRINOTECAN-INDUCED SEVERE DIARRHEA: MECHANISMS, BIOMAKER AND PREVENTIO

Author:Sun, Rongjin; Zhu, Lijun; Gao, Song; Liu, Zhongqiu; Hu, Ming

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:

9
MODEL-BASED EXPLORATION OF PARENT-METABOLITE KINETICS OF MT-202: NONCLINICAL CHARACTERIZATION AND FEASIBILITY OF CLINICAL METABOLITE EXPOSURE PREDICTIO

Author:Sun, Austin; Smukste, Inese; Dowling, James E.; McTeague, T. Andrew; Yan, Liping; Zhou, Xiaoying; Bursavich, Matthew G.; Lippa, Blaise; Tang, Cuyue

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:

10
CHALLENGES OF AN ACTIVE METABOLITE: THE POTENTIAL OF DISPROPORTIONATE HUMAN EXPOSURE AND THE COMPLEX KINETICS UPON DRUG-DRUG INTERACTION

Author:Smukste, Inese; Sun, Austin; Dowling, James; Mcteague, Andrew; Yan, Liping; Zhou, Xiaoying; Bursavich, Matthew; Lippa, Blaise; Tang, Cuyue

Journal: DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. 61, Issue , pp. -. DOI:


在线咨询

Drug Metabolism And Pharmacokinetics

国际简称:DRUG METAB PHARMACOK参考译名:药物代谢和药代动力学

年发文量:36 CiteScore:5.2 是否预警:否 Gold OA文章占比:18.75% 研究类文章占比:88.89%

杂志社联系方式:JAP SOC STUDY XENOBIOTICS, INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, JAPAN, 160-0016

Drug Metabolism And Pharmacokinetics